4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000030
Chief Medical Officer sold 642 shares at $25.14 ($16,140)
- Chief Medical Officer acquired 2,162 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gheuens Sarah · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-12 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,162 | 34,073 | D | ||
| 2024-02-14 | Sale : show line 2 in the form 10b5-1 | −642 | $25.14 | $16,140 | 33,431 | D |
| Open-market sales · 642 sh · avg $25.14 · $16,140 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-12 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units | −2,162 | 0 | D |
Loading xslF345X05/wk-form4_1707951190.xml…